Non-invasive diagnosis and follow-up of portal hypertension

Autor: Victor de Lédinghen, Thomas Sersté, Christophe Bureau, Marika Rudler, Dominique Thabut, Nathalie Ganne-Carrié, Delphine Weil, Charlotte Bouzbib, Laurent Castera, Christophe Cassinotto, Frédéric Oberti, M. Bourlière

Publikováno v: Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (8), pp.101767. ⟨10.1016/j.clinre.2021.101767⟩

Compensated advanced chronic liver disease (cACLD) describes the spectrum of advanced fibrosis/cirrhosis in asymptomatic patients at risk of developing clinically significant portal hypertension (CSPH, defined by a hepatic venous pressure gradient (H

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1cb9fe6b34441779db973812ba272d94
https://www.hal.inserm.fr/inserm-04048906

French recommendations for the management of systemic sclerosis

Autor: Hachulla, Eric, Agard, Christian, Allanore, Yannick, Avouac, Jérôme, Bader-Meunier, Brigitte, Belot, Alexandre, Berezne, Alice, Bouthors, Anne-Sophie, Condette-Wojtasik, Geraldine, Constans, Joël, de Groote, Pascal, Diot, Elisabeth, Dumas, Florence, Jego, Patrick, Joly, Francisca, Launay, David, Le Guern, Veronique, Le Quintrec, Janine-Sophie, Lescaille, Géraldine, Meune, Christophe, Moulin, Bruno, Nguyen, Christelle, Omeish, Nadine, Pene, Frédéric, Richard, Marie-Aleth, Rochefort, Juliette, Roren, Alexandra, Sitbon, Olivier, Sobanski, Vincent, Truchetet, Marie-Elise, Mouthon, Luc, Bayen, Marc, Bergot, Emmanuel, Berthier, Sabine, Bosco, Julia, Bouhnik, Yoram, Chaigne, Benjamin, Cottin, Vincent, Crestani, Bruno, Deligny, Christophe, Descroix, Vianney, Farge, Dominique, Godard, Dominique, Granel, Brigitte, Guilpain, Philippe, Imbert, Bernard, Le Quellec, Alain, Lega, Christophe, Lok, Catherine, Maillard, Hélène, Martin, Thierry, Pugnet, Grégory, Queyrel, Viviane, Raffray, Loïc, Rilliard, Frédéric, Romier, Mélanie, Schuller, Laurence, Servettaz, Amélie

Publikováno v: Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 2021, 16 (S2), pp.322. ⟨10.1186/s13023-021-01844-y⟩
Orphanet Journal of Rare Diseases, Vol 16, Iss S2, Pp 1-61 (2021)

Systemic sclerosis (SSc) is a generalized disease of the connective tissue, arterioles, and microvessels, characterized by the appearance of fibrosis and vascular obliteration. There are two main phenotypical forms of SSc: a diffuse cutaneous form th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::504d094b55ec08caf7f7d0091ae61673
https://hal.science/hal-03652133/file/s13023-021-01844-y.pdf

Outcome of patients hospitalized for Covid‐19 and exposure to angiotensin‐converting enzyme inhibitors and angiotensin‐receptor blockers in France: Results of the ACECoV study

Autor: Guillaume Moulis, Guillaume Martin-Blondel, Sandrine Charpentier, Agnès Sommet, Pierre Delobel, Margaux Lafaurie

Publikováno v: Fundamental & Clinical Pharmacology
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, Wiley, 2021, Fundamental & Clinical Pharmacology, 35 (1), pp.194-203. ⟨10.1111/fcp.12613⟩
Fundamental and Clinical Pharmacology, Wiley, 2021, Fundamental & Clinical Pharm acology, 35 (1), pp.192-193. ⟨10.1111/fcp.12637⟩
Fundamental & Clinical Pharmacology, 2021, Fundamental & Clinical Pharmacology, 35 (1), pp.194-203. ⟨10.1111/fcp.12613⟩

International audience; Data are lacking on the impact of ACEI/ARB exposure on unfavorable outcome in the population of patients hospitalized for COVID‐19 with hypertension/cardiovascular disease, particularly in Europe. The ACE‐CoV study was des

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b24f27b39587cffd0a47de8cd57662a

The association between social support and medication adherence in patients with hypertension: a systematic review

Autor: Ieva Stupans, Gerard A. Kennedy, Wejdan Shahin

Publikováno v: Pharmacy Practice (Granada) v.19 n.2 2021
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Pharmacy Practice, Vol 19, Iss 2, p 2300 (2021)
Pharmacy Practice
SciELO España: Revistas Científicas Españolas de Ciencias de la Salud
Instituto de Salud Carlos III (ISCIII)

Background: Medication adherence is a primary determinant of treatment success in hypertensive patients. One of the challenges for healthcare providers that has received little attention is the impact of patients’ social supports on medication adhe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a32b6ec86fbee4bef8498eea84c558fd
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2021000200007

Loss-of-function mutations in MRAP2 are pathogenic in hyperphagic obesity with hyperglycemia and hypertension

Autor: Cécile Aubert, Maithé Tauber, Ronan Roussel, Bénédicte Toussaint, François Pattou, Philippe Froguel, Jean-Michel Borys, Amjad Ghulam, Hélène Loiselle, Mathilde Boissel, Emmanuelle Durand, Sylvia Franc, Julie Kerr-Conte, Julie Maillet, Morgane Baron, Marlène Huyvaert, Amélie Bonnefond, Raphaël Boutry, J. Philippe, Jérémy Thomas, Guillaume Charpentier, Claire Lévy-Marchal, Michel Marre, Mehdi Derhourhi, Aurélie Dechaume, Emmanuel Vaillant, B. Balkau, Stefan Gaget, Raphael Scharfmann, Jacques Weill, Mickaël Canouil

Publikováno v: Nature Medicine
Nature Medicine, 2019, 25 (11), pp.1733-1738. ⟨10.1038/s41591-019-0622-0⟩
Nature medicine
Nature Medicine, Nature Publishing Group, 2019, 25 (11), pp.1733-1738. ⟨10.1038/s41591-019-0622-0⟩

International audience; The G-protein-coupled receptor accessory protein MRAP2 is implicated in energy control in rodents, notably via the melanocortin-4 receptor1. Although some MRAP2 mutations have been described in people with obesity1-3, their fu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90e4070864d7e526bb4fbf52762499c4
https://www.hal.inserm.fr/inserm-02439220/document